Skip to main content

Table 3 Clinical factors for TBR ≥ 1% analyzed by multivariate logistic regression analysis

From: The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study

  Odds ratio 95% CI P value
CV
 Insulin treatment 1.49 0.54–4.13 0.4426
 History of stroke or TIA 1.59 0.41–6.25 0.5056
 HbA1c 1.17 0.45–3.13 0.7548
 FPG 0.99 0.97–1.00 0.1420
 CPI 1.09 0.67–1.92 0.7408
 CV 1.43 1.28–1.65 < 0.0001
 TAR 0.90 0.84–0.95 0.0005
SD
 Insulin treatment 1.76 0.68–4.54 0.2398
 History of stroke or TIA 1.58 0.44–5.66 0.4856
 HbA1c 0.99 0.42–2.33 0.9757
 FPG 0.99 0.97–1.00 0.0956
 CPI 1.03 0.65–1.71 0.8929
 SD 1.27 1.17–1.41 < 0.0001
 TAR 0.79 0.71–0.86 < 0.0001
MAGE
 Insulin treatment 2.35 0.93–5.94 0.0720
 History of stroke or TIA 2.08 0.59–7.35 0.2535
 HbA1c 1.13 0.51–2.53 0.7611
 FPG 0.98 0.97–1.00 0.0850
 CPI 0.90 0.57–1.45 0.6560
 MAGE 1.07 1.04–1.10 < 0.0001
 TAR 0.84 0.78–0.90 < 0.0001
  1. TIA transient ischemic attack, FPG fasting plasma glucose, CPI C-peptide index, CV coefficient of variation, SD standard deviation, MAGE mean amplitude of glycemic excursions, CI confidence interval, TAR time above target glucose range, TBR time below target glucose range